Results
1 -
10 of
10Huppertz Laura M., Bisel Philippe, Westphal Folker, Franz Florian, Auwärter Volker, Moosmann Bjoern.
Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites, Forensic Toxicology, 2015 Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes, Analytical and Bioanalytical Chemistry Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam, European Journal of Clinical Pharmacology Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples, The AAPS Journal Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788, Naunyn-Schmiedeberg's Archives of Pharmacology Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects, Psychopharmacology Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788, Psychopharmacology Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections, Antimicrobial Drug Resistance Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use, Parasitology Research